Literature DB >> 23053040

[Small renal mass].

D Prokofiev1, N Kreutzer, A Kress, F Wissing, H Pfeifer, J-U Stolzenburg, A Dietel, T Schwalenberg, M Do, M C Truß.   

Abstract

The frequent application of ultrasound and radiological imaging for non-urological indications in recent years has resulted in an increase in the diagnosis of small renal masses. The treatment options for patients with a small renal mass include active surveillance, surgery (both open and minimally invasive) as well as ablative techniques. As there is a risk for metastatic spread even in small renal masses surgical extirpation remains the treatment of choice in most patients. Ablative procedures, such as cryoablation and radiofrequency ablation are appropriate for old and multi-morbid patients who require active treatment of a small renal mass. Active surveillance is an alternative for high-risk patients. Meticulous patient selection by the urologist and patient preference will determine the choice of treatment option in the future.

Entities:  

Mesh:

Year:  2012        PMID: 23053040     DOI: 10.1007/s00120-012-2960-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  19 in total

Review 1.  Clinical practice. Small renal mass.

Authors:  Inderbir S Gill; Monish Aron; Debra A Gervais; Michael A S Jewett
Journal:  N Engl J Med       Date:  2010-02-18       Impact factor: 91.245

2.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.

Authors:  Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Marc Colombel; Laurence Klotz; Eila Skinner; Thomas Keane; Sandrine Marreaud; Sandra Collette; Richard Sylvester
Journal:  Eur Urol       Date:  2010-12-22       Impact factor: 20.096

3.  Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter.

Authors:  Mesut Remzi; Mehmet Ozsoy; Hans-Christoph Klingler; Martin Susani; Matthias Waldert; Christian Seitz; Joerg Schmidbauer; Michael Marberger
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

4.  Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup.

Authors:  A F Fergany; K S Hafez; A C Novick
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

5.  Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses.

Authors:  Frank J Rybicki; Kirstin M Shu; Edmund S Cibas; Julia R Fielding; Eric vanSonnenberg; Stuart G Silverman
Journal:  AJR Am J Roentgenol       Date:  2003-05       Impact factor: 3.959

6.  Rising incidence of small renal masses: a need to reassess treatment effect.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

7.  Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older.

Authors:  Brian R Lane; Robert Abouassaly; Tianming Gao; Christopher J Weight; Adrian V Hernandez; Benjamin T Larson; Jihad H Kaouk; Inderbir S Gill; Steven C Campbell
Journal:  Cancer       Date:  2010-07-01       Impact factor: 6.860

Review 8.  The natural history of observed enhancing renal masses: meta-analysis and review of the world literature.

Authors:  Sam N Chawla; Paul L Crispen; Alexandra L Hanlon; Richard E Greenberg; David Y T Chen; Robert G Uzzo
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

Review 9.  Changing concepts in the surgical management of renal cell carcinoma.

Authors:  John S Lam; Oleg Shvarts; Allan J Pantuck
Journal:  Eur Urol       Date:  2004-06       Impact factor: 20.096

Review 10.  A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.

Authors:  Roman Heuer; Inderbir S Gill; Giorgio Guazzoni; Ziya Kirkali; Michael Marberger; Jerome P Richie; Jean J M C H de la Rosette
Journal:  Eur Urol       Date:  2009-10-20       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.